Literature DB >> 22461176

Peroxisome proliferator-activated receptor-γ protects against vascular aging.

Mary L Modrick1, Dale A Kinzenbaw, Yi Chu, Curt D Sigmund, Frank M Faraci.   

Abstract

Vascular disease occurs commonly during aging. Carotid artery and cerebrovascular disease are major causes of stroke and contributors to dementia. Recent evidence suggests that peroxisome proliferator-activated receptor-γ (PPARγ) may play a protective role in the vasculature, but the potential importance of PPARγ in vascular aging is unknown. To examine the hypothesis that PPARγ normally protects against vascular aging, we studied heterozygous knockin mice expressing a human dominant-negative mutation in PPARγ (P465L, designated L/+). Endothelial dysfunction, a major contributor to vascular disease, was studied using carotid arteries from adult (8 ± 1 mo) and old (24 ± 1 mo) L/+ mice and wild-type littermates. In arteries from wild-type mice, responses to the endothelium-dependent agonist ACh were similar in adult and old wild-type mice but were reduced by ∼50% in old L/+ mice (n = 7-10, P < 0.05). Impaired responses in arteries from old L/+ mice were restored to normal by a scavenger of superoxide. Relaxation of arteries to nitroprusside (an NO donor) was similar in all groups. Contraction of arteries to U46619 was not affected by age or genotype, while maximal responses to endothelin-1 were reduced with age in both wild-type and L/+ mice. Vascular expression (mRNA) of the catalytic component of NADPH oxidase (Nox2) was not altered in wild-type mice but was increased significantly in old L/+ mice. These findings provide the first evidence that interference with PPARγ function accelerates vascular aging, suggesting a novel role for PPARγ in protecting against age-induced oxidative stress and endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461176      PMCID: PMC3362146          DOI: 10.1152/ajpregu.00557.2011

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  48 in total

1.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; R A Kronmal; T A Manolio; G L Burke; S K Wolfson
Journal:  N Engl J Med       Date:  1999-01-07       Impact factor: 91.245

2.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

3.  Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase.

Authors:  F M Faraci; C D Sigmund; E G Shesely; N Maeda; D D Heistad
Journal:  Am J Physiol       Date:  1998-02

4.  Aging decreases vasoconstrictor responses of coronary resistance arterioles through endothelium-dependent mechanisms.

Authors:  Robert D Shipley; Judy M Muller-Delp
Journal:  Cardiovasc Res       Date:  2004-12-08       Impact factor: 10.787

5.  Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes.

Authors:  Servio H Ramirez; David Heilman; Brenda Morsey; Raghava Potula; James Haorah; Yuri Persidsky
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

6.  Altered cholesterologenic and lipogenic transcriptional profile in livers of aging Snell dwarf (Pit1dw/dwJ) mice.

Authors:  William H Boylston; Arpad Gerstner; James H DeFord; Mark Madsen; Kevin Flurkey; David E Harrison; John Papaconstantinou
Journal:  Aging Cell       Date:  2004-10       Impact factor: 9.304

7.  PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice.

Authors:  Michael J Ryan; Sean P Didion; Satya Mathur; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2004-01-26       Impact factor: 10.190

8.  Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain.

Authors:  Laibaik Park; Josef Anrather; Helene Girouard; Ping Zhou; Costantino Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-11       Impact factor: 6.200

Review 9.  Vascular protection: superoxide dismutase isoforms in the vessel wall.

Authors:  Frank M Faraci; Sean P Didion
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-27       Impact factor: 8.311

Review 10.  The nuclear hormone receptor PPARγ as a therapeutic target in major diseases.

Authors:  Martina Victoria Schmidt; Bernhard Brüne; Andreas von Knethen
Journal:  ScientificWorldJournal       Date:  2010-11-04
View more
  15 in total

1.  Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.

Authors:  T Michael De Silva; Ying Li; Dale A Kinzenbaw; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

2.  Sex and basic science. A Title IX position.

Authors:  Kathryn Sandberg; Joseph G Verbalis; Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-18       Impact factor: 3.619

3.  Endothelin-1 but not angiotensin II contributes to functional aging in murine carotid arteries.

Authors:  Matthias R Meyer; Natalie C Fredette; Matthias Barton; Eric R Prossnitz
Journal:  Life Sci       Date:  2014-03-05       Impact factor: 5.037

4.  Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular aging.

Authors:  Matthias R Meyer; Matthias Barton; Eric R Prossnitz
Journal:  Life Sci       Date:  2013-12-29       Impact factor: 5.037

Review 5.  Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Md Jakaria; Abdullah Al Mamun; Kamal Niaz; Md Shah Amran; George E Barreto; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2019-05-04       Impact factor: 3.911

6.  Prostanoid-mediated contractions of the carotid artery become Nox2-independent with aging.

Authors:  Matthias R Meyer; Natalie C Fredette; Matthias Barton; Eric R Prossnitz
Journal:  Age (Dordr)       Date:  2015-08-01

7.  Interleukin-10 protects against aging-induced endothelial dysfunction.

Authors:  Dale A Kinzenbaw; Yi Chu; Ricardo A Peña Silva; Sean P Didion; Frank M Faraci
Journal:  Physiol Rep       Date:  2013-11-11

Review 8.  Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?

Authors:  T Michael De Silva; Alyson A Miller
Journal:  Front Pharmacol       Date:  2016-03-17       Impact factor: 5.810

Review 9.  PPARγ and RhoBTB1 in hypertension.

Authors:  Shi Fang; Curt D Sigmund
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-03       Impact factor: 3.416

Review 10.  The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia.

Authors:  Maria Luca; Antonina Luca; Carmela Calandra
Journal:  Oxid Med Cell Longev       Date:  2015-08-02       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.